TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After Surgery
Condition: HER2-positive Breast Cancer Interventions: Drug: TAHP and AHP; Drug: TAHP plus AC and AHP Sponsor: Samsung Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials